Form 4: Oscar Health's President of Technology & CTO, Mario Schlosser, Reports Stock Sales

Mario Schlosser, President of Technology & CTO of Oscar Health, Inc., reported the sale of Class A Common Stock to cover tax obligations related to vesting equity awards.

Summary

• On June 1, 2024, Mario Schlosser exercised restricted stock units, acquiring 14,411 shares of Class A Common Stock.
• Following this, Schlosser sold 5,808 shares on June 3, 2024, at an average price of $19.46.
• An additional 152 shares were sold on June 4, 2024, at an average price of $19.09.
• These sales were executed to satisfy tax withholding obligations upon the vesting of previously granted equity awards, pursuant to a Rule 10b5-1 trading plan established before February 27, 2023.
• After these transactions, Schlosser directly owns 65,768 shares of Class A Common Stock and 158,529 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing indicates routine stock sales for tax purposes, which is a common practice. There's no indication of unusual or concerning activity.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating they were planned well in advance and not based on immediate market conditions.

Industry Context

Insider trading activity is closely monitored, and Form 4 filings provide transparency into the transactions of company executives and directors. Sales to cover tax obligations are common and generally viewed as less significant than discretionary sales.

Stakeholder Impact

• The stock sales may have a minor, short-term impact on the stock price, but are unlikely to significantly affect long-term shareholder value.

Key Dates